Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -30.4% | 20.4% | 21.9% | – |
| Gross Profit | -£0 | £0 | £0 | -£13 |
| % Margin | -4.8% | 2.2% | 27.6% | -694,329.5% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -65.1% | -9% | -57.6% | -69.4% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -115.2% | -44.7% | -99.8% | -102.6% |
| EPS Diluted | -0.007 | -0.004 | -0.008 | -0.006 |
| % Growth | -80% | 46.7% | -19% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£9 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£2 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£11 |